LIPID-PEROXIDATION AND ANTIOXIDATIVE ENZYME LEVELS IN TAMOXIFEN-TREATED WOMEN WITH BREAST-CANCER, IN RELATION TO THE MENOPAUSAL STATUS OF THE PATIENTS

被引:0
|
作者
THANGARAJU, M [1 ]
ILANCHEZHIAN, S [1 ]
EZHILARASI, R [1 ]
SACHDANANDAM, P [1 ]
机构
[1] UNIV MADRAS,DEPT MED BIOCHEM,DR AIMPGIBMS,TARAMANI CAMPUS,MADRAS 600113,INDIA
来源
MEDICAL SCIENCE RESEARCH | 1993年 / 21卷 / 19期
关键词
TAMOXIFEN; BREAST CANCER; MENOPAUSE; LIPID PEROXIDATION; ANTIOXIDATIVE ENZYMES;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:721 / 723
页数:3
相关论文
共 50 条
  • [1] Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status
    Ilanchezhian, S
    Thangaraju, M
    Sachdanandam, P
    CANCER BIOCHEMISTRY BIOPHYSICS, 1995, 15 (02): : 83 - 90
  • [2] ENDOMETRIAL CARCINOMA IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS
    SPINELLI, G
    BARDAZZI, N
    CITERNESI, A
    FONTANAROSA, M
    CURIEL, P
    JOURNAL OF CHEMOTHERAPY, 1991, 3 (04) : 267 - 270
  • [3] Effect of Vitamin C on Lipidperoxidation and Antioxidant Status in Tamoxifen-Treated Breast Cancer Patients
    Muralikrishnan, G.
    Amanullah, S.
    Basha, M. I.
    Boopalan, S.
    Vijayakumar, S.
    Shakeel, F.
    CHEMOTHERAPY, 2010, 56 (04) : 298 - 302
  • [4] EFFECT OF TAMOXIFEN ON LIPID PEROXIDE AND ANTIOXIDATIVE SYSTEM IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER
    THANGARAJU, M
    VIJAYALAKSHMI, T
    SACHDANANDAM, P
    CANCER, 1994, 74 (01) : 78 - 82
  • [5] DNA-CONTENT IN ENDOMETRIAL CARCINOMA OF TAMOXIFEN-TREATED BREAST-CANCER PATIENTS
    MOBERGER, B
    FORNANDER, T
    HELLSTROM, AC
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 (02) : 131 - 134
  • [6] Ovarian cysts in tamoxifen-treated women with breast cancer
    Inal, MM
    Incebiyik, A
    Sanci, M
    Yildirim, Y
    Polat, M
    Pilanci, B
    Nayki, C
    Camuzcuoglu, H
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 120 (01): : 104 - 106
  • [7] Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients
    Ximenez, Joao Paulo Bianchi
    de Andrade, Jurandyr Moreira
    Marques, Maria Paula
    Coelho, Eduardo Barbosa
    Suarez-Kurtz, Guilherme
    Lanchote, Vera Lucia
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (Suppl 1)
  • [8] Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer
    Shushan, A
    Peretz, T
    Uziely, B
    Lewin, A
    MorYosef, S
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (01) : 141 - 144
  • [9] THE POSSIBLE ROLE OF LIPID-PEROXIDATION IN BREAST-CANCER RISK
    BOYD, NF
    MCGUIRE, V
    FREE RADICAL BIOLOGY AND MEDICINE, 1991, 10 (3-4) : 185 - 190
  • [10] Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer
    Georgopoulos, Neoklis A.
    Adonakis, George L.
    Fotopoulos, Andreas
    Koika, Vasiliki
    Spinos, Nikitas
    Saltamavros, Alexandros
    Keramopoulos, Antonios
    Koukouras, Dimitrios
    Decavalas, George
    Kourounis, George S.
    GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (04) : 185 - 189